SHL Telemedicine Ltd. (SWX:SHLTN)
Switzerland · Delayed Price · Currency is CHF 1.070
0.00 (0.00%)
Oct 23, 2026, 5:30 PM CEST
SHL Telemedicine Market Cap
SHL Telemedicine has a market cap or net worth of 39.65 million as of October 23, 2026. It is the 30,355th most valuable company in the world and the 195th biggest in Switzerland. Its market cap has increased by 101.59% in one year.
Market Cap
39.65M
Enterprise Value
32.70M
Revenue
50.17M
Global Rank
Country Rank
#195 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since November 14, 2000, SHL Telemedicine's market cap has decreased from 229.59M to 39.65M, a decrease of -82.73%. That is a compound annual growth rate of -6.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 39.65M | -9.32% |
| Dec 30, 2025 | 43.73M | 2.61% |
| Dec 30, 2024 | 42.62M | -62.59% |
| Dec 29, 2023 | 113.92M | -47.37% |
| Dec 30, 2022 | 216.45M | -21.67% |
| Dec 30, 2021 | 276.35M | 121.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 312.94B |
| Novartis AG | 241.16B |
| Lonza Group AG | 43.55B |
| Galderma Group AG | 40.63B |
| Ascom Holding AG | 196.20M |
| Newron Pharmaceuticals | 180.53M |
| BioVersys AG | 145.46M |
| Molecular Partners AG | 116.45M |